SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041590
Filing Date
2023-08-11
Accepted
2023-08-11 07:07:57
Documents
87
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agle-20230630.htm   iXBRL 10-Q 3783260
2 EX-10.3 agle-ex10_3.htm EX-10.3 112265
3 EX-10.4 agle-ex10_4.htm EX-10.4 340841
4 EX-10.5 agle-ex10_5.htm EX-10.5 18304
5 EX-10.6 agle-ex10_6.htm EX-10.6 18453
6 EX-10.7 agle-ex10_7.htm EX-10.7 153356
7 EX-10.8 agle-ex10_8.htm EX-10.8 75331
8 EX-10.9 agle-ex10_9.htm EX-10.9 704819
9 EX-31.1 agle-ex31_1.htm EX-31.1 18078
10 EX-32.1 agle-ex32_1.htm EX-32.1 10137
11 GRAPHIC img71546535_0.jpg GRAPHIC 8893
12 GRAPHIC img71546535_1.jpg GRAPHIC 8893
13 GRAPHIC img71546535_2.jpg GRAPHIC 3333
14 GRAPHIC img116985424_0.jpg GRAPHIC 43565
  Complete submission text file 0000950170-23-041590.txt   13684124

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agle-20230630_pre.xml EX-101.PRE 455122
16 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agle-20230630.xsd EX-101.SCH 69756
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agle-20230630_def.xml EX-101.DEF 344256
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agle-20230630_lab.xml EX-101.LAB 517593
19 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agle-20230630_cal.xml EX-101.CAL 59046
81 EXTRACTED XBRL INSTANCE DOCUMENT agle-20230630_htm.xml XML 2187027
Mailing Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37722 | Film No.: 231161488
SIC: 2834 Pharmaceutical Preparations